| Single Dose Escalation Study of CM383 in Healthy Volunteers (NCT06412185) | Keymed Biosciences Co.Ltd | 2024-05-28 |
| A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MKND-201 in Healthy Volunteers (NCT06532942) | Mannkind Corporation | 2024-05-28 |
| Pausing Antiretroviral Treatment Under Structured Evaluation (NCT06031272) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2024-05-28 |
| Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male Participants (NCT06417229) | Celgene | 2024-05-28 |
| Intratumoral CAN2109 in Subjects With Solid Tumors (NCT06332430) | Canwell Biotech Limited | 2024-05-28 |
| A Research Study of the Effect of Food on Etavopivat in Healthy Participants (NCT06433661) | Novo Nordisk A/S | 2024-05-28 |
| A Study to Evaluate Safety, Tolerability, and PK of DA-7503 in Healthy Adult and Elderly Participants (NCT06391827) | Dong-A ST Co., Ltd. | 2024-05-27 |
| A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PB-119 Injection in Chinese Obese Subjects (NCT06350812) | PegBio Co., Ltd. | 2024-05-27 |
| Safety and Immunogenicity of a Sub-unit Protein CD40.RBDv Bivalent COVID-19 Vaccine, Adjuvanted or Not, as a Booster in Volunteers. (NCT06255626) | ANRS, Emerging Infectious Diseases | 2024-05-27 |
| Phase 1 Study Assessing the Pharmacokinetics of NEX-22A in Subjects With T2D (NCT06439056) | Nanexa AB | 2024-05-27 |
| A Study to Evaluate the MNV-201 in Patients With Low Risk MDS (NCT06465160) | Minovia Therapeutics Ltd. | 2024-05-27 |
| A Clinical Study of HMPL-506 in Patients With Hematological Malignancies (NCT06387082) | Hutchmed | 2024-05-27 |
| Linperlisib Combined With Chidamide in Patients With PTCL (NCT06421948) | Yanyan Liu | 2024-05-25 |
| Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple Myeloma (NCT06375044) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2024-05-24 |
| Clinical Trial of Targeted Alpha Therapy Using [At-211]PSMA-5 for Prostate Cancer (NCT06441994) | Osaka University | 2024-05-24 |
| Immunotherapy Rechallenge in Patients with Solid Tumors in Clinical Trials (NCT06612632) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2024-05-24 |
| First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors (NCT06402201) | CDR-Life AG | 2024-05-24 |
| Umbilical-Cord-Derived Mesenchymal Stem Cells Injection for Chronic Radiation Proctitis (NCT06438809) | Jiangsu Topcel-KH Pharmaceutical Co., Ltd. | 2024-05-24 |
| A Study of GLB-001 in Patients With Myeloid Malignancies (NCT06378437) | Hangzhou GluBio Pharmaceutical Co., Ltd. | 2024-05-24 |
| A Phase 1b Study to Evaluate the Safety of XEN-101 (NCT06417697) | Xeno Biosciences | 2024-05-24 |
| Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors (NCT04715191) | Baylor College of Medicine | 2024-05-24 |
| TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors. (NCT06297642) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-05-24 |
| Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome (NCT06195891) | City of Hope Medical Center | 2024-05-24 |
| Febuxostat Effect on Chronic Kidney Disease Progression And Carotid Intima-Media Thickness (NCT06997952) | Ain Shams University | 2024-05-24 |
| Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors (NCT06445062) | Revolution Medicines, Inc. | 2024-05-24 |
| The Clinical Study of SHR-7631 for Injection in Patients With Advanced Solid Tumors (NCT06381050) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-05-24 |
| Managing Chronic Tendon Pain by Metformin (NCT06100822) | James Wang | 2024-05-24 |
| CBD for Pain Following Orthopedic Shoulder Surgery (NCT06381791) | The Methodist Hospital Research Institute | 2024-05-24 |
| A Study to Investigate Treatment of HU and VPA, or 6-MP and VPA in Unfit AML/HR-MDS Patients (NCT06199557) | Haukeland University Hospital | 2024-05-23 |
| Safety and Efficacy of Stem Cell Small Extracellular Vesicles in Patients With Retinitis Pigmentosa (NCT06242379) | Mahidol University | 2024-05-23 |
| The Bioequivalence Study of Fixed-dose Combination of Vildagliptin and Metformin HCI 50/1000 mg FCT Under Fed Conditions (NCT06244407) | International Bio service | 2024-05-23 |
| Different Levels of BiPAP (NCT06421519) | King's College Hospital NHS Trust | 2024-05-23 |
| Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects (NCT06422039) | Shandong Suncadia Medicine Co., Ltd. | 2024-05-23 |
| A Study of GQ1010 in Subjects With Advanced Solid Tumors (NCT06464055) | GeneQuantum Healthcare (Suzhou) Co., Ltd. | 2024-05-23 |
| A Phase I/IIa，Open-label, Single Ascending Dose and Dose-expansion Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of YOLT-201 in Patients With Transthyretin Amyloidosis Polyneuropathy (ATTR-PN) or Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM) (NCT06539208) | YolTech Therapeutics Co., Ltd | 2024-05-23 |
| A STUDY TO LEARN HOW THE STUDY MEDICINE CALLED PF-07293893 AFFECTS MUSCLE BIOMARKERS OF HEALTHY ADULTS (NCT06413693) | Pfizer | 2024-05-23 |
| A Study About Modified RNA Vaccines Against Influenza in Healthy Adults (NCT06436703) | Pfizer | 2024-05-23 |
| A Study of PET/CT Imaging Using INR101 Injection in Healthy Male Subjects and Patients With Suspected Prostate Cancer (NCT06472531) | Yunhe Pharmaceutical (Tianjin) Co., Ltd | 2024-05-23 |
| A Study With BPI-1178 and Osimertinib in Advanced Non-small Cell Lung Cancer Patients With EGFR Mutations (NCT06362980) | National Cancer Center, China | 2024-05-22 |
| Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer (NCT06343402) | TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics) | 2024-05-22 |
| A Study of TQC3927 Powder for Inhalation in Healthy Adult Subjects (NCT06408285) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-05-22 |
| This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors (NCT06451497) | Zumutor Biologics Inc. | 2024-05-22 |
| A Study in Healthy Men to Test Whether Esomeprazole Influences the Amount of BI 3000202 in the Blood (NCT06419660) | Boehringer Ingelheim | 2024-05-22 |
| LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer (NCT06303713) | Dana-Farber Cancer Institute | 2024-05-22 |
| Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state. (NCT06773767) | Aziende Chimiche Riunite Angelini Francesco S.p.A | 2024-05-22 |
| A Phase I/II Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia (NCT06235801) | M.D. Anderson Cancer Center | 2024-05-22 |
| Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors (NCT06320405) | OHSU Knight Cancer Institute | 2024-05-21 |
| A Phase 1b Study of WU-NK-101 in Combination With Cetuximab (NCT05674526) | Allotera Therapeutics | 2024-05-21 |
| Clinical Study Aiming to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a Single Administration of ZE50-0134 at 5 Dose Levels in Healthy Volunteers (NCT06787131) | Lomond Therapeutics Holdings, Inc. | 2024-05-21 |
| Study of AU409 Capsule in Advanced Hepatocellular Carcinoma Patients Who Failed Standard Treatment (NCT06374485) | Lee's Pharmaceutical Limited | 2024-05-21 |
| A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor (NCT06024408) | Regeneron Pharmaceuticals | 2024-05-21 |
| A Study of SNDX-5613 in Combination With Intensive Chemotherapy in Participants With Acute Myeloid Leukemias (NCT06226571) | Syndax Pharmaceuticals | 2024-05-21 |
| Study of [14C] ABBV-CLS-7262 in Healthy Male Volunteers Following Single Oral Dose Administration (NCT06425003) | Calico Life Sciences LLC | 2024-05-21 |
| A Microneurography Study of NaV1.8 Inhibition in Healthy Adults (NCT06420765) | Vertex Pharmaceuticals Incorporated | 2024-05-21 |
| Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain (NCT06053242) | Creative Medical Technology Holdings Inc | 2024-05-21 |
| Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (NCT06015880) | National Cancer Institute (NCI) | 2024-05-20 |
| A Research Study on Etavopivat in Participants With and Without Liver Disease (NCT06336018) | Novo Nordisk A/S | 2024-05-20 |
| Safety and Efficacy of CAR T Cell Therapy in Patients with R/r B-ALL (NCT06635330) | Kara Yakhteh Tajhiz Azma Company | 2024-05-20 |
| A Tolerability, Safety and Efficacy Study of RJMty19 in Subjects With Relapsed or Refractory B-NHL (NCT06314828) | Guangdong Ruishun Biotech Co., Ltd | 2024-05-20 |
| Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) (NCT06353386) | Merck Sharp & Dohme LLC | 2024-05-20 |
| A Study of the Effect of Itraconazole and Phenytoin on Calderasib (MK-1084) in Healthy Adults (MK-1084-008) (NCT06719557) | Merck Sharp & Dohme LLC | 2024-05-20 |
| Phase I Study of HC-7366 for Acute Myeloid Leukemia (NCT06285890) | M.D. Anderson Cancer Center | 2024-05-20 |
| Protocol Title: Safety and Feasibility of Autologous CD34+ Hematopoietic Stem Cells Mobilization and Apheresis in Participants With RUNX1 Familial Platelet Disorder (NCT06414889) | M.D. Anderson Cancer Center | 2024-05-20 |
| A Study of LY4170156 in Participants With Selected Advanced Solid Tumors (NCT06400472) | Eli Lilly and Company | 2024-05-20 |
| AMT-562 in Patients With Selected Advanced Solid Tumors (NCT06199908) | Multitude Therapeutics (Australia) Pty Ltd | 2024-05-20 |
| A Study of TAK-853 in Adult Participants With Folate Receptor Alpha-Positive Advanced Ovarian Cancer And Other Solid Tumors (NCT06390995) | Takeda | 2024-05-20 |
| PK/PD Study of SHR-2017 Injection in Patients With Bone Metastases (NCT06380881) | Suzhou Suncadia Biopharmaceuticals Co., Ltd. | 2024-05-20 |
| Frontal iTBS for Impulsivity and Suicidal Ideation in Veterans With Mild Traumatic Brain Injury (NCT05647044) | VA Office of Research and Development | 2024-05-20 |
| Safety and Tolerability of IBI355 in Healthy Volunteers (NCT06416787) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-05-20 |
| A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors (NCT06328439) | Avistone Biotechnology Co., Ltd. | 2024-05-19 |
| A Study to Learn About How BAY 3283142 Moves Into, Through, and Out of the Body After a Single Dose in Participants With Reduced Liver Function Compared to Participants With Normal Liver Function (NCT06402721) | Bayer | 2024-05-17 |
| Phase I Study Evaluating Tolerability, Safety, Pharmacokinetics, and Efficacy of Combined ONO-4059 and R-MPV Therapy for PCNSL (NCT06541665) | Ono Pharmaceutical Co., Ltd. | 2024-05-17 |
| SAD Evaluation of Safety, Tolerability, PK, and PD of MDI-2517 in Healthy Participants (NCT06453824) | MDI Therapeutics, Inc. | 2024-05-17 |
| Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy (NCT06369467) | Regeneron Pharmaceuticals | 2024-05-17 |
| A Study to Evaluate the Pharmacokinetics and Safety Between HCP2303 and Co-administration of Each Component in Healthy Volunteers Under Fed Conditions (NCT06357910) | Hanmi Pharmaceutical Company Limited | 2024-05-17 |
| Clinical Study to Evaluate the Safety and Tolerability of PRO-229 Ophthalmic Solution Compared to Lagricel® Ofteno PF (NCT06370585) | Laboratorios Sophia S.A de C.V. | 2024-05-16 |
| Pharmacokinetic Profile and Safety of Fluticasone Propionate and Albuterol Sulfate in Combination When Compared to Fluticasone Propionate Multidose Dry Powder Inhaler (Fp MDPI) in Children Aged 4 to 11 Years Old (NCT06290102) | Teva Branded Pharmaceutical Products R&D, Inc. | 2024-05-16 |
| The Study of Pharmacokinetics and Pharmacodynamics of Huperzine A Injection in Healthy Chinese Subjects (NCT06570655) | Wanbangde Pharmaceutical Group Co., LTD | 2024-05-16 |
| Phase 1b/2 Study of LDRT in Combination With AK104 Plus Chemotherapy as First-line Treatment for ES-SCLC (NCT06477523) | Sichuan University | 2024-05-16 |
| Autologous T-cells Genetically Engineered to Express Receptors Reactive Against KRAS Mutations in Conjunction With a Vaccine Directed Against These Antigens in Participants With Metastatic Cancer (NCT06253520) | National Cancer Institute (NCI) | 2024-05-16 |
| Single-ascending Dose Study of Kylo-11 in Healthy Subjects (NCT06363851) | Kylonova (Xiamen) Biopharma co., LTD. | 2024-05-16 |
| MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP (NCT06361108) | Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. | 2024-05-16 |
| First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers (NCT06493045) | Integrative Research Laboratories AB | 2024-05-16 |
| A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants (NCT06368440) | AstraZeneca | 2024-05-15 |
| A Study of ASP1012 in Adults With Solid Tumors (NCT06171178) | Astellas Pharma Global Development, Inc. | 2024-05-15 |
| Infusion of Allogeneic Stromal Mesenchymal Stem Cells From Wharton´s Jelly in Patients With Diffuse Cutaneous Systemic Sclerosis With Refractory Pulmonary Involvement to Treatment (NCT07542067) | Fundación Neumologica Colombiana | 2024-05-15 |
| Rapalog Pharmacology (RAP PAC) Study (NCT05949658) | University of Wisconsin, Madison | 2024-05-15 |
| Safety and Efficacy of KLS-1 Monotherapy in Malignant Neoplasms (NCT06506643) | Vector Vitale LLC | 2024-05-15 |
| Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. (NCT06581562) | IRIS Research and Development, LLC | 2024-05-15 |
| Study to Evaluate a New Method to Detect Residual Tumours During Surgery for Prostate Cancer Using Confocal Microscopy (NCT06398470) | University College, London | 2024-05-15 |
| A Study of JMT203 in Patients With Cancer Cachexia (NCT06868849) | Shanghai JMT-Bio Inc. | 2024-05-15 |
| A Phase Ib/II Study of BY101298 , an Oral DNA-PK Inhibitor, Combined with Radiotherapy in Patients with Malignant Solid Tumors (NCT06524804) | Chengdu Baiyu Pharmaceutical Co., Ltd. | 2024-05-15 |
| A PK Study to Compare GME751 (Proposed Pembrolizumab Biosimilar) and US-licensed and EU-authorized Keytruda® in Participants With Stage II and III Melanoma (NCT06153238) | Sandoz | 2024-05-15 |
| A Study of MT027 in Patients with Pleural Malignant Tumors (NCT06726564) | Suzhou Maximum Bio-tech Co., Ltd. | 2024-05-15 |
| A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems (NCT06352411) | Boehringer Ingelheim | 2024-05-15 |
| Study to Evaluate the Safety and Efficacy of CSB-001 Ophthalmic Solution 0.1% in Subjects With Limbal Stem Cell Deficiency (NCT06452316) | Claris Biotherapeutics, Inc. | 2024-05-15 |
| A Study in Healthy Men and Women to Test Whether BI 1569912 Influences the Amount of Repaglinide, Midazolam and Bupropion in the Blood (NCT06367153) | Boehringer Ingelheim | 2024-05-15 |
| Study to Assess the Safety, Tolerability, Pharmacokinetic of Thrv-1268 (NCT06507839) | Thryv Therapeutics, Inc. | 2024-05-15 |
| A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM) (NCT06280703) | Eli Lilly and Company | 2024-05-15 |
| Effect of Intravenous Dexmedetomidine Versus Dexamethasone for Management of Repound Pain After Supraclavicular Brachial Plexus Block (NCT06304909) | Assiut University | 2024-05-15 |